Literature DB >> 22427231

The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis.

Young Ho Lee1, Sang-Cheol Bae, Sung Jae Choi, Jong Dae Ji, Gwan Gyu Song.   

Abstract

OBJECTIVE: The aim of this study was to determine whether the functional interleukin-6 (IL-6) promoter -174 G/C and -572 G/C polymorphisms confer susceptibility to rheumatoid arthritis (RA) in ethnically different populations.
METHODS: Meta-analysis was conducted on the associations between these IL-6 polymorphisms and RA.
RESULTS: A total of nine studies involving 3,851 subjects (RA 2,053 and controls 1,798) were considered in this study and ethnicity-specific meta-analysis was performed on European subjects. In all study subjects, meta-analysis revealed a trend toward to an association between RA and the IL-6 -174 G allele (odds ratio [OR] = 0.699, 95 % confidence interval [CI] = 0.463-1.054, p = 0.088). Stratification by ethnicity indicated a significant association between RA and the IL-6 -174 G/C polymorphism in Europeans using the dominant (OR = 0.329, 95 % CI = 0.155-0.699, p = 0.004) and recessive (OR = 0.823, 95 % CI = 0.679-0.997, p = 0.047) models. Meta-analysis of the IL-6 -572 G/C polymorphism showed no association between RA and the IL-6 -572 G allele in all study subjects (OR = 1.641, 95 % CI = 0.613-4.397, p = 0.324).
CONCLUSIONS: This meta-analysis shows that the IL-6 -174 G/C polymorphism may confer susceptibility to RA in Europeans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427231     DOI: 10.1007/s00011-012-0459-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  35 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Genome scan meta-analysis of rheumatoid arthritis.

Authors:  S J Choi; Y H Rho; J D Ji; G G Song; Y H Lee
Journal:  Rheumatology (Oxford)       Date:  2005-11-08       Impact factor: 7.580

3.  IL-6 promoter polymorphism in patients with rheumatoid arthritis.

Authors:  A Pawlik; J Wrzesniewska; M Florczak; B Gawronska-Szklarz; M Herczynska
Journal:  Scand J Rheumatol       Date:  2005 Mar-Apr       Impact factor: 3.641

4.  Investigation of novel polymorphisms within the 3' region of the IL-6 gene in patients with rheumatoid arthritis using Genescan analysis.

Authors:  A Crilly; J M Bartlett; A White; D Stirling; H Capell; R Madhok
Journal:  Cytokine       Date:  2001-01-21       Impact factor: 3.861

Review 5.  The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.

Authors:  Y H Lee; Y H Rho; S J Choi; J D Ji; G G Song; S K Nath; J B Harley
Journal:  Rheumatology (Oxford)       Date:  2006-06-07       Impact factor: 7.580

6.  Interleukin 6 gene polymorphisms are associated with systemic lupus erythematosus in Koreans.

Authors:  Ja-Young Jeon; Hyoun-Ah Kim; Seung-Hyun Kim; Hae-Sim Park; Chang-Hee Suh
Journal:  J Rheumatol       Date:  2010-09-15       Impact factor: 4.666

7.  Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis.

Authors:  Mark P S Sie; Fakhredin A Sayed-Tabatabaei; Hok-Hay S Oei; André G Uitterlinden; Hubert A P Pols; Albert Hofman; Cornelia M van Duijn; Jacqueline C M Witteman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-11-03       Impact factor: 8.311

8.  Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking.

Authors:  Vasileios F Panoulas; Antonios Stavropoulos-Kalinoglou; Giorgos S Metsios; Jacqueline P Smith; Haralampos J Milionis; Karen M J Douglas; Peter Nightingale; George D Kitas
Journal:  Atherosclerosis       Date:  2008-09-06       Impact factor: 5.162

9.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

10.  PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis.

Authors:  Young Ho Lee; Young Hee Rho; Seong Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2007-01-31       Impact factor: 3.580

View more
  15 in total

1.  A posteriori evaluation of effects attributed to IL-6 gene regulatory variants.

Authors:  Philipp G Sand
Journal:  Inflamm Res       Date:  2012-06-27       Impact factor: 4.575

2.  Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis.

Authors:  Vahid Ziaee; Marzieh Maddah; Mohammad-Hassan Moradinejad; Arezou Rezaei; Samaneh Zoghi; Maryam Sadr; Sara Harsini; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2016-09-20       Impact factor: 2.980

Review 3.  Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

Authors:  Lili Magyari; Dalma Varszegi; Erzsebet Kovesdi; Patricia Sarlos; Bernadett Farago; Andras Javorhazy; Katalin Sumegi; Zsolt Banfai; Bela Melegh
Journal:  World J Orthop       Date:  2014-09-18

4.  Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators.

Authors:  Hung N Nguyen; Erika H Noss; Fumitaka Mizoguchi; Christine Huppertz; Kevin S Wei; Gerald F M Watts; Michael B Brenner
Journal:  Immunity       Date:  2017-02-21       Impact factor: 31.745

5.  Genetic and environmental determinants of population variation in interleukin-6, its soluble receptor and C-reactive protein: insights from identical and fraternal twins.

Authors:  Wellington Z Amaral; Robert F Krueger; Carol D Ryff; Christopher L Coe
Journal:  Brain Behav Immun       Date:  2015-06-15       Impact factor: 7.217

6.  Functional FCGR3A 158 V/F and IL-6 -174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2014-04-12       Impact factor: 2.631

7.  Flavonoid quercetin-methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis.

Authors:  Nagaraja Haleagrahara; Kelly Hodgson; Socorro Miranda-Hernandez; Samuel Hughes; Anupama Bangra Kulur; Natkunam Ketheesan
Journal:  Inflammopharmacology       Date:  2018-04-03       Impact factor: 4.473

8.  TGF-β1 limits the onset of innate lung inflammation by promoting mast cell-derived IL-6.

Authors:  Kirthana Ganeshan; Laura K Johnston; Paul J Bryce
Journal:  J Immunol       Date:  2013-04-29       Impact factor: 5.422

Review 9.  IL-6 in inflammation, immunity, and disease.

Authors:  Toshio Tanaka; Masashi Narazaki; Tadamitsu Kishimoto
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-04       Impact factor: 10.005

10.  Potential of ayurgenomics approach in complex trait research: leads from a pilot study on rheumatoid arthritis.

Authors:  Ramesh C Juyal; Sapna Negi; Preeti Wakhode; Sulekha Bhat; Bheema Bhat; B K Thelma
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.